AGH vs REGN · rev $3.3M vs P/E 14, rev $14.34B
Aureus Greenway Holdings Inc. Common Stock (AGH) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Aureus Greenway Holdings Inc. Common Stock (AGH) is a leisure company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported AGH revenue for 2024-12-31 was $3.3M. Net income was -$183.7K. Revenue was down 7.2% from 2023-12-31 to 2024-12-31. AGH currently screens at market cap $93.5M.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
AGH currently screens at market cap $93.5M. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the AGH and REGN stock pages for the full models.
Not investment advice.